*
Eikon search string for individual stock moves: STXBZ
*
The Day Ahead newsletter: https://refini.tv/3LI4BU7
*
The Morning News Call newsletter: https://refini.tv/3dKUyB8
U.S. stock indexes fell on Wednesday, as investors locked in profits after a
strong 2023 and awaited the Federal Reserve's December meeting minutes that
could offer hints on its interest rate path. .N
At 10:46 ET, the Dow Jones Industrial Average .DJI was down 0.80% at
37,413.84. The S&P 500 .SPX was down 0.80% at 4,704.77 and the Nasdaq
Composite .IXIC was down 1.03% at 14,614.38.
The top three S&P 500 .PG.INX percentage gainers:
** Eli Lilly LLY.N , up 3%
** Marathon Petroleum MPC.N , up 2.9%
** Arch Capital Group ACGL.O , up 2.5%
The top three S&P 500 .PL.INX percentage losers:
** Enphase Enrgy ENPH.O , down 8.8%
** Align Tech ALGN.O , down 6.9%
** Albemarle ALB.N , down 6.7%
The top three NYSE .PG.N percentage gainers:
** TDCX TDCX.N , up 31.7%
** China Green Agriculture CGA.N , up 16.8%
** Bright Health Group BHG.N , up 16.6%
The top two NYSE .PL.N percentage losers:
** Banyan Acquisition PNST.N , down 32.5%
** Altisource Asset Management AAMC.N , down 21.9%
The top three Nasdaq .PG.O percentage gainers:
** NexImmune NEXI.O , up 224.2%
** Sidus Space SIDU.O , up 65.4%
** Sigma Additive Solutions SASI.O , up 46.2%
The top three Nasdaq .PL.O percentage losers:
** Esperion Therapeutics ESPR.O , down 27.1%
** TC BioPharm TCBP.O , down 22.8%
** Peraso PRSO.O , down 22.2%
** SoFi Technologies SOFI.O : down 14.0%
BUZZ - Falls as KBW turns bearish after stock's recent run urn:newsml:reuters.com:*:nL4N3DT1BF
** Dyne Therapeutics DYN.O : up 10.6%
BUZZ - Jumps on positive data for muscular disorder drugs urn:newsml:reuters.com:*:nL4N3DT1NU
** Agios Pharmaceuticals AGIO.O : up 3.4%
BUZZ - Rises as blood disorder drug meets late-stage study goals urn:newsml:reuters.com:*:nL4N3DT1NO
** Regeneron Pharmaceuticals REGN.O : up 1.0%
BUZZ - Leerink sees increased sales for Regeneron's eye drug, raises PT -
Reuters urn:newsml:reuters.com:*:nL4N3DT1PF
** Coinbase Global COIN.O : down 4.5%
** Bitfarms BITF.O : down 4.9%
** Riot Platforms RIOT.O : down 5.7%
** Marathon Digital Holdings MARA.O : down 2.9%
BUZZ - Crypto stocks slide as bitcoin comes off 21-month high urn:newsml:reuters.com:*:nL4N3DT1SC
** Merck & Co MRK.N : up 1.7%
BUZZ - Citi picks Merck as its preferred pharma stock urn:newsml:reuters.com:*:nL4N3DT1PY
** ABVC BioPharma ABVC.O : up 53.3%
BUZZ - Up on receiving $460 mln worth shares under licensing deal urn:newsml:reuters.com:*:nL4N3DT1TP
** Xponential Fitness XPOF.N : down 6.8%
BUZZ - Falls after Piper Sandler downgrades to 'neutral' urn:newsml:reuters.com:*:nL4N3DT1VG
** Newmont Corp NEM.N : down 3.2%
** Barrick Gold Corp GOLD.N : down 2.4%
** AngloGold Ashanti Ltd AU.N : down 2.0%
** Harmony Gold Mining Co Ltd HMY.N : down 2.3%
BUZZ - Gold miners slip on stronger dollar urn:newsml:reuters.com:*:nL4N3DT285
** SentinelOne S.N : down 5.1%
BUZZ - To acquire PingSafe, shares drop urn:newsml:reuters.com:*:nL4N3DT21K
** Pure Storage PSTG.N : up 5.7%
BUZZ - Rises after inclusion in S&P mid-cap index, Stifel PT raise urn:newsml:reuters.com:*:nL4N3DT238
** Pfizer PFE.N : up 0.3%
BUZZ - Up on Canada approval for bleeding disorder gene therapy urn:newsml:reuters.com:*:nL4N3DT24Q
** Suncor Energy SU.N : up 4.4%
BUZZ - Rises after flagging second-highest output in Q4 urn:newsml:reuters.com:*:nL4N3DT280
** Southern First Bancshares SFST.O : up 3.3%
BUZZ - Rises after Piper Sandler upgrades to 'overweight' urn:newsml:reuters.com:*:nL4N3DD35Q
** Sarepta Therapeutics SRPT.O : down 2.6%
BUZZ - Down after Dyne's drug trial for muscle disorder shows better result
urn:newsml:reuters.com:*:nL4N3DT27C
The 11 major S&P 500 sectors:
Communication Services .SPLRCL down 0.05%
Consumer Discretionary .SPLRCD down 1.47%
Consumer Staples .SPLRCS down 0.22%
Energy .SPNY up 0.63%
Financial .SPSY down 0.98%
Health .SPXHC down 0.09%
Industrial .SPLRCI down 1.36%
Information Technology .SPLRCT down 1.03%
Materials .SPLRCM down 1.71%
Real Estate .SPLRCR down 2.36%
Utilities .SPLRCU up 0.06%
(Compiled by Rajarshi Roy and Kabir Dweit)
((Rajarshi.Roy@thomsonreuters.com))